RIA Advisory Group LLC lowered its holdings in Kodiak Sciences Inc. (NASDAQ:KOD – Free Report) by 49.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 75,036 shares of the company’s stock after selling 74,540 shares during the quarter. RIA Advisory Group […]
Shares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) have earned an average recommendation of “Moderate Buy” from the seven research firms that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year […]
Kodiak Sciences (NASDAQ:KOD – Get Rating) and Novozymes A/S (OTCMKTS:NVZMY – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Risk and Volatility Kodiak Sciences has a beta of 1.77, […]
Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) has been given a consensus rating of “Moderate Buy” by the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month […]
Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) has been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price […]